Sean X. Naughton et al., 2020-01-18: Primary rat cortical neuron study showing methylene blue prevented organophosphate (DFP)-induced impairment of axonal transport, a non-cholinesterase endpoint, without any claim of cholinesterase reactivation.
both LiCl and MB prevented DFP-induced impairments in anterograde and retrograde axonal transport velocities in a concentration dependent manner.
Abstract
Sean X. Naughton et al., 2020-01-18: Primary rat cortical neuron study showing methylene blue prevented organophosphate (DFP)-induced impairment of axonal transport, a non-cholinesterase endpoint, without any claim of cholinesterase reactivation. Laboratory study in primary rat cortical neuronal cultures with time-lapse live imaging. Country: United States (Augusta University). Concentrations: range tested in the full text; the abstract reports concentration-dependent protection. Route: in vitro. Funder: NIH R01 GM118915 and R35 GM136397. Conflicts: 'The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.' Comparator: DFP-exposed neurons without MB; LiCl as a second repurposed compound. Bearing: PARTLY SUPPORTS because there is real laboratory evidence that methylene blue mitigates some organophosphate toxicity – but by protecting axonal transport, not by reactivating acetylcholinesterase, and only in vitro. Study type: lab.
